Benzene uptake and glutathione S-transferase T1 status as determinants of S-phenylmercapturic acid in cigarette smokers in the multiethnic cohort

PLoS ONE

Volumn 11, Issue 3, 2016, Pages

  Haiman, Christopher A ^a   Patel, Yesha M ^a   Stram, Daniel O ^a   Carmella, Steven G ^b   Chen, Menglan ^b   Wilkens, Lynne R ^c   Le Marchand, Loic ^c   Hecht, Stephen S ^b  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b UNIVERSITY OF MINNESOTA   (United States)

^c UNIVERSITY OF HAWAII CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCYSTEINE DERIVATIVE; BENZENE; GLUTATHIONE TRANSFERASE M1; GLUTATHIONE TRANSFERASE T1; PHENYLMERCAPTURIC ACID; UNCLASSIFIED DRUG; ACETYLCYSTEINE; GLUTATHIONE S-TRANSFERASE T1; GLUTATHIONE TRANSFERASE; S-PHENYL-N-ACETYLCYSTEINE;

ADULT; AFRICAN AMERICAN; AGED; ARTICLE; ASIAN AMERICAN; CANCER RISK; CAUCASIAN; COHORT ANALYSIS; CONTROLLED STUDY; ETHNIC DIFFERENCE; FEMALE; GENE DELETION; GENETIC ASSOCIATION; GENETIC RISK; GENOTYPE; GSTM1 GENE; GSTT1 GENE; HISPANIC; HUMAN; LUNG CANCER; MALE; NATIVE HAWAIIAN; RISK FACTOR; SMOKING; URINALYSIS; ANALOGS AND DERIVATIVES; GENOME-WIDE ASSOCIATION STUDY; METABOLISM; MIDDLE AGED; QUALITY CONTROL;

ACETYLCYSTEINE; AGED; BENZENE; FEMALE; GENOME-WIDE ASSOCIATION STUDY; GENOTYPE; GLUTATHIONE TRANSFERASE; HUMANS; MALE; MIDDLE AGED; QUALITY CONTROL; RISK FACTORS; SMOKING;

EID: 84962547722     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0150641     Document Type: Article

References (57)

1. Haiman CA, Stram DO, Wilkens LR, Pike MC, Kolonel LN, Henderson BE, et al. Ethnic and racial differences in the smoking-related risk of lung cancer. N Engl J Med. 2006; 354(4):333-42. Epub 2006/01/27
2. Gadgeel SM, Severson RK, Kau Y, Graff J, Weiss LK, Kalemkerian GP. Impact of race in lung cancer: analysis of temporal trends from a surveillance, epidemiology, and end results database. Chest. 2001; 120(1):55-63. PMID: 11451816
3. Harris RE, Zang EA, Anderson JI, Wynder EL. Race and sex differences in lung cancer risk associated with cigarette smoking. Int J Epidemiol. 1993; 22:592-9. PMID: 8225730
4. Hinds MW, Stemmermann GN, Yang HY, Kolonel LN, Lee J, Wegner E. Differences in lung cancer risk from smoking among Japanese, Chinese and Hawaiian women in Hawaii. Int J Cancer. 1981; 27 (3):297-302. PMID: 7287220
5. Le Marchand L, Wilkens LR, Kolonel LN. Ethnic differences in the lung cancer risk associated with smoking. Cancer Epidemiol Biomarkers Prev. 1992; 1(2):103-7. Epub 1992/01/01. PMID: 1306091.
6. Schwartz AG, Swanson GM. Lung carcinoma in African Americans and whites. A population-based study in metropolitan Detroit, Michigan. Cancer. 1997; 79(1):45-52. PMID: 8988725
7. Sobue T, Yamamoto S, Hara M, Sasazuki S, Sasaki S, Tsugane S. Cigarette smoking and subsequent risk of lung cancer by histologic type in middle-aged Japanese men and women: the JPHC study. Int J Cancer. 2002; 99(2):245-51. PMID: 11979440
8. Stellman SD, Takezaki T, Wang L, Chen Y, Citron ML, Djordjevic MV, et al. Smoking and lung cancer risk in American and Japanese men: An international case-control study. Cancer Epidemiol Biomarkers Prev. 2001; 10:1193-9. PMID: 11700268
9. Blot WJ, Cohen SS, Aldrich M, McLaughlin JK, Hargreaves MK, Signorello LB. Lung cancer risk among smokers of menthol cigarettes. J Natl Cancer Inst. 2011; 103(10):810-6. doi: 10.1093/jnci/djr102 PMID: 21436064
10. Chen LS, Saccone NL, Culverhouse RC, Bracci PM, Chen CH, Dueker N, et al. Smoking and genetic risk variation across populations of European, Asian, and African American ancestry - a meta-analysis of chromosome 15q25. Genet Epidemiol. 2012; 36(4):340-51. doi: 10.1002/gepi.21627 PMID: 22539395
11. Zhan P, Wang Q, Qian Q, Wei SZ, Yu LK. CYP1A1 MspI and exon7 gene polymorphisms and lung cancer risk: an updated meta-analysis and review. J Exp Clin Cancer Res. 2011; 30:99. doi: 10.1186/1756-9966-30-99 PMID: 22014025
12. Chen B, Qiu LX, Li Y, Xu W, Wang XL, Zhao WH, et al. The CYP1B1 Leu432Val polymorphism contributes to lung cancer risk: evidence from 6501 subjects. Lung Cancer. 2010; 70(3):247-52. doi: 10.1016/ j.lungcan.2010.03.011 PMID: 20395011
13. Carpenter CL, Yu MC, London SJ. Dietary isothiocyanates, glutathione S-transferase M1 (GSTM1), and lung cancer risk in African Americans and Caucasians from Los Angeles County, California. Nutr Cancer. 2009; 61(4):492-9. doi: 10.1080/01635580902752270 PMID: 19838921
14. Kiyohara C, Takayama K, Nakanishi Y. Lung cancer susceptibility and hOGG1 ser326Cys polymorphism: a meta-analysis. Cancers (Basel). 2010; 2(4):1813-29.
15. Truong T, Sauter W, McKay JD, Hosgood HD III, Gallagher C, Amos CI, et al. International Lung Cancer Consortium: coordinated association study of 10 potential lung cancer susceptibility variants. Carcinogenesis. 2010; 31(4):625-33. doi: 10.1093/carcin/bgq001 PMID: 20106900
16. Murphy SE, Park SS, Thompson EF, Wilkens LR, Patel Y, Stram DO, et al. Nicotine N-glucuronidation relative to N-oxidation and C-oxidation and UGT2B10 genotype in five ethnic/racial groups. Carcinogenesis. 2014; 35(11):2526-33. Epub 2014/09/23. doi: 10.1093/carcin/bgu191 bgu191 [pii]. PMID: 25233931; PubMed Central PMCID: PMC4216060.
17. Park SL, Carmella SG, Ming X, Vielguth E, Stram DO, Le Marchand L, et al. Variation in levels of the lung carcinogen NNAL and its glucuronides in the urine of cigarette smokers from five ethnic groups with differing risks for lung cancer. Cancer Epidemiol Biomarkers Prev. 2015; 24(3):561-9. Epub 2014/ 12/30. doi: 10.1158/1055-9965.EPI-14-1054 1055-9965.EPI-14-1054 [pii]. PMID: 25542827; PubMed Central PMCID: PMC4355389.
18. Patel YM, Stram DO, Wilkens LR, Park SS, Henderson BE, Le Marchand L, et al. The contribution of common genetic variation to nicotine and cotinine glucuronidation in multiple ethnic/racial populations. Cancer Epidemiol Biomarkers Prev. 2014. Epub 2014/10/09. doi: 1055-9965.EPI-14-0815 [pii] doi: 10. 1158/1055-9965.EPI-14-0815 PMID: 25293881.
19. Park SL, Carmella SG, Chen M, Patel Y, Stram DO, Haiman CA, et al. Mercapturic acids derived from the toxicants acrolein and crotonaldehyde in the urine of cigarette smokers from five ethnic groups with differing risks for lung cancer. PLoS One. 2015; 10(6):e0124841. doi: 10.1371/journal.pone.0124841 PMID: 26053186.
20. International Agency for Research on Cancer. A Review of Human Carcinogens: Chemical Agents and Related Occupations. IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, Vol 100F. Lyon, FR: IARC; 2012. p. 249-94.
21. National Toxicology Program. 12th Report on Carcinogens. Washington DC: US Department of Health and Human Services; 2011 2011.
22. Roemer E, Stabbert R, Rustemeier K, Veltel DJ, Meisgen TJ, ReininghausW, et al. Chemical composition, cytotoxicity and mutagenicity of smoke from US commercial and reference cigarettes smoked under two sets of machine smoking conditions. Toxicology. 2004; 195(1):31-52. PMID: 14698566
23. Wallace L. Environmental exposure to benzene: an update. Environ Health Perspect. 1996; 104 Suppl 6:1129-36. PMID: 9118882
24. Carmella SG, Chen M, Han S, Briggs A, Jensen J, Hatsukami DK, et al. Effects of smoking cessation on eight urinary tobacco carcinogen and toxicant biomarkers. Chem Res Toxicol. 2009; 22(4):734-41. doi: 10.1021/tx800479s PMID: 19317515
25. Williams PR. An analysis of violations of Osha's (1987) occupational exposure to benzene standard. J Toxicol Environ Health B Crit Rev. 2014; 17(5):259-83. doi: 10.1080/10937404.2014.924452 PMID: 25205215.
26. Hecht SS. Tobacco smoke carcinogens and lung cancer. J Natl Cancer Inst. 1999; 91(14):1194-210. Epub 1999/07/21. PMID: 10413421.
27. Hecht SS. Human urinary carcinogen metabolites: biomarkers for investigating tobacco and cancer. Carcinogenesis. 2002; 23:907-22. PMID: 12082012
28. Hecht SS, Yuan J-M, Hatsukami DK. Applying tobacco carcinogen and toxicant biomarkers in product regulation and cancer prevention. Chem Res Toxicol. 2010; 23:1001-8. doi: 10.1021/tx100056m PMID: 20408564
29. Dougherty D, Garte S, Barchowsky A, Zmuda J, Taioli E. NQO1, MPO, CYP2E1, GSTT1 and GSTM1 polymorphisms and biological effects of benzene exposure - a literature review. Toxicol Lett. 2008; 182 (1-3):7-17. doi: 10.1016/j.toxlet.2008.09.008 PMID: 18848868
30. Hoet P, De Smedt E, Ferrari M, Imbriani M, Maestri L, Negri S, et al. Evaluation of urinary biomarkers of exposure to benzene: correlation with blood benzene and influence of confounding factors. Int Arch Occup Environ Health. 2009; 82(8):985-95. doi: 10.1007/s00420-008-0381-6 PMID: 19009306.
31. Scheepers PT, Coggon D, Knudsen LE, Anzion R, Autrup H, Bogovski S, et al. BIOMarkers for occupational diesel exhaust exposure monitoring (BIOMODEM) - a study in underground mining. Toxicol Lett. 2002; 134(1-3):305-17. PMID: 12191893
32. Sorensen M, Poole J, Autrup H, Muzyka V, Jensen A, Loft S, et al. Benzene exposure assessed by metabolite excretion in Estonian oil shale mineworkers: influence of glutathione S-transferase polymorphisms. Cancer Epidemiol Biomarkers Prev. 2004; 13(11 Pt 1):1729-35. PMID: 15533900
33. Qu Q, Shore R, Li G, Su L, Jin X, Melikian AA, et al. Biomarkers of benzene: urinary metabolites in relation to individual genotype and personal exposure. Chem BiolInteract. 2005; 153-154:85-95.
34. Avogbe PH, Ayi-Fanou L, Autrup H, Loft S, Fayomi B, Sanni A, et al. Ultrafine particulate matter and high-level benzene urban air pollution in relation to oxidative DNA damage. Carcinogenesis. 2005; 26 (3):613-20. PMID: 15591089
35. Kim S, Lan Q, Waidyanatha S, Chanock S, Johnson BA, Vermeulen R, et al. Genetic polymorphisms and benzene metabolism in humans exposed to a wide range of air concentrations. Pharmacogenet Genomics. 2007; 17(10):789-801. PMID: 17885617
36. Lin LC, Chen WJ, Chiung YM, Shih TS, Liao PC. Association between GST genetic polymorphism and dose-related production of urinary benzene metabolite markers, trans, trans-muconic acid and S-phenylmercapturic acid. Cancer Epidemiol Biomarkers Prev. 2008; 17(6):1460-9. doi: 10.1158/1055-9965.EPI-08-0160 PMID: 18559562
37. Manini P, De Palma G, Andreoli R, Mozzoni P, Poli D, Goldoni M, et al. Occupational exposure to low levels of benzene: Biomarkers of exposure and nucleic acid oxidation and their modulation by polymorphic xenobiotic metabolizing enzymes. Toxicol Lett. 2010; 193(3):229-35. doi: 10.1016/j.toxlet.2010. 01.013 PMID: 20100551
38. Mansi A, Bruni R, Capone P, Paci E, Pigini D, Simeoni C, et al. Low occupational exposure to benzene in a petrochemical plant: modulating effect of genetic polymorphisms and smoking habit on the urinary t,t-MA/SPMA ratio. Toxicol Lett. 2012; 213(1):57-62. doi: 10.1016/j.toxlet.2011.02.001 PMID: 21300142
39. Carrieri M, Bartolucci GB, Scapellato ML, Spatari G, Sapienza D, Soleo L, et al. Influence of glutathione S-transferases polymorphisms on biological monitoring of exposure to low doses of benzene. Toxicol Lett. 2012; 213(1):63-8. doi: 10.1016/j.toxlet.2011.11.031 PMID: 22173199
40. Egner PA, Chen JG, Zarth AT, Ng D, Wang J, Kensler KH, et al. Rapid and sustainable detoxication of airborne pollutants by broccoli sprout beverage: results of a randomized clinical trial in china. Cancer Prev Res (Phila). 2014. Epub 2014/06/11. doi: canprevres.0103.2014 [pii] 1940-6207.CAPR-14-0103 [pii] doi: 10.1158/1940-6207.CAPR-14-0103 PMID: 24913818.
41. Kolonel LN, Henderson BE, Hankin JH, Nomura AM, Wilkens LR, Pike MC, et al. A multiethnic cohort in Hawaii and Los Angeles: baseline characteristics. Am J Epidemiol. 2000; 151(4):346-57. PMID: 10695593.
42. Carmella SG, Chen M, Zarth A, Hecht SS. High throughput liquid chromatography-tandem mass spectrometry assay for mercapturic acids of acrolein and crotonaldehyde in cigarette smokers' urine. J Chromatogr B Analyt Technol Biomed Life Sci. 2013; 935:36-40. Epub 2013/08/13. doi: 10.1016/j.jchromb. 2013.07.004 S1570-0232(13)00371-1 [pii]. PMID: 23934173; PubMed Central PMCID: PMC3925436.
43. Wang J, Liang Q, Mendes P, Sarkar M. Is 24h nicotine equivalents a surrogate for smoke exposure based on its relationship with other biomarkers of exposure? Biomarkers. 2011; 16(2):144-54. Epub 2011/02/18. doi: 10.3109/1354750X.2010.536257 PMID: 21323604.
44. Carmella SG, Ming X, Olvera N, Brookmeyer C, Yoder A, Hecht SS. High throughput liquid and gas chromatography-tandem mass spectrometry assays for tobacco-specific nitrosamine and polycyclic aromatic hydrocarbon metabolites associated with lung cancer in smokers. Chem Res Toxicol. 2013; 26(8):1209-17. Epub 2013/07/11. doi: 10.1021/tx400121n PMID: 23837805; PubMed Central PMCID: PMC3803150.
45. Delaneau O, Marchini J, Zagury J-F. A linear complexity phasing method for thousands of genomes. Nat Methods. 2011; 9(2):179-81. doi: 10.1038/nmeth.1785 PMID: 22138821
46. Howie BN, Donnelly P, Marchini J. A flexible and accurate genotype imputation method for the next generation of genome-wide association studies. PLoS Genet. 2009; 5(6):e1000529. Epub 2009/06/23. doi: 10.1371/journal.pgen.1000529 PMID: 19543373; PubMed Central PMCID: PMC2689936.
47. Yang J, Lee SH, Goddard ME, Visscher PM. GCTA: a tool for genome-wide complex trait analysis. Am J Hum Genet. 2011; 88(1):76-82. Epub 2010/12/21. doi: 10.1016/j.ajhg.2010.11.011 S0002-9297(10) 00598-7 [pii]. PMID: 21167468; PubMed Central PMCID: PMC3014363.
48. Devlin B, Roeder K. Genomic control for association studies. Biometrics. 1999; 55(4):997-1004. PMID: 11315092.
49. Fowles J, Dybing E. Application of toxicological risk assessment principles to the chemical constituents of cigarette smoke. Tob Control. 2003; 12(4):424-30. PMID: 14660781; PubMed Central PMCID: PMC1747794.
50. Burns DM, Dybing E, Gray N, Hecht S, Anderson C, Sanner T, et al. Mandated lowering of toxicants in cigarette smoke: a description of the World Health Organization TobReg proposal. Tob Control. 2008; 17(2):132-41. doi: 10.1136/tc.2007.024158 PMID: 18375736; PubMed Central PMCID: PMC2569138.
51. International Agency for Research on Cancer. A review of human carcinogens: chemical agents and related occupations. IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, Vol 100F. Lyon, FR: IARC; 2012. p. 309-38.
52. National Toxicology Program. NTP toxicology and carcinogenesis studies of benzene (CAS No. 71-43-2) in F344/N rats and B6C3F1 mice (Gavage Studies). Natl Toxicol Program Tech Rep Ser. 1986; 289:1-277. PMID: 12748714.
53. Hecht SS. Biochemistry, biology, and carcinogenicity of tobacco-specific N-nitrosamines. Chem ResToxicol. 1998; 11:559-603.
54. Zarth AT, Murphy SE, Hecht SS. Benzene oxide is a substrate for glutathione S-transferases. Chem Biol Interact. 2015; 242:390-5. doi: 10.1016/j.cbi.2015.11.005 PMID: 26554337; PubMed Central PMCID: PMC4695229.
55. Nelson HH, Wiencke JK, Christiani DC, Cheng TJ, Zuo ZF, Schwartz BS, et al. Ethnic differences in the prevalence of the homozygous deleted genotype of glutathione S-transferase theta. Carcinogenesis. 1995; 16(5):1243-5. PMID: 7767992.
56. Monks TJ, Butterworth M, Lau SS. The fate of benzene-oxide. Chem Biol Interact. 2010; 184(1-2):201-6. doi: 10.1016/j.cbi.2009.12.025 PMID: 20036650
57. McHale CM, Zhang L, Smith MT. Current understanding of the mechanism of benzene-induced leukemia in humans: implications for risk assessment. Carcinogenesis. 2012; 33(2):240-52. doi: 10.1093/ carcin/bgr297 PMID: 22166497